Osaic Holdings
SIOX

Osaic Holdings’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Osaic Holdings’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-86
Closed – – 7637
2022
Q4 		$0 Hold
86
– – ﹤0.01% 7613
2022
Q3 		$0 Hold
86
– – ﹤0.01% 7674
2022
Q2 		$0 Hold
86
– – ﹤0.01% 7751
2022
Q1 		$0 Hold
86
– – ﹤0.01% 7707
2021
Q4 		$0 Hold
86
– – ﹤0.01% 7707
2021
Q3 		$0 Sell
86
-1,000
-92% -$2.17K ﹤0.01% 7418
2021
Q2 		$3K Hold
1,086
– – ﹤0.01% 6649
2021
Q1 		$3K Hold
1,086
– – ﹤0.01% 6433
2020
Q4 		$3K Buy
1,086
+1,006
+1,258% +$2.93K ﹤0.01% 6010
2020
Q3 		$0 Sell
80
-324
-80% -$1.07K ﹤0.01% 6505
2020
Q2 		$1K Hold
404
– – ﹤0.01% 6032
2020
Q1 		$1K Buy
+404
New +$1.46K ﹤0.01% 5976

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Osaic Holdings's SIOX Position: Q1 2023 in Review

Osaic Holdings sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 86 shares.

Osaic Holdings first reported a position in SIOX in Q1 2020 and held it in 12 quarters. The position peaked at $3K in Q2 2021. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Osaic Holdings reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Osaic Holdings sold 86 Sio Gene Therapies Inc. Common Stock shares in Q1 2023.
  • Osaic Holdings first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2020 and held it in 12 quarters.
  • Osaic Holdings's Sio Gene Therapies Inc. Common Stock position peaked at $3K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.